HomeKNE • CVE
add
Kane Biotech Inc
Previous close
$0.040
Day range
$0.035 - $0.035
Year range
$0.025 - $0.12
Market cap
5.86M CAD
Avg Volume
357.26K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 8.50K | -99.34% |
Operating expense | 538.31K | -53.99% |
Net income | -607.34K | -0.25% |
Net profit margin | -7.15K | -15,030.38% |
Earnings per share | — | — |
EBITDA | -445.94K | 21.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 939.06K | 72.50% |
Total assets | 2.74M | -29.83% |
Total liabilities | 3.53M | -23.08% |
Total equity | -793.37K | — |
Shares outstanding | 167.35M | — |
Price to book | ∞ | — |
Return on assets | -41.47% | — |
Return on capital | -70.33% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -607.34K | -0.25% |
Cash from operations | -698.22K | -29.75% |
Cash from investing | 54.39K | 743.04% |
Cash from financing | -30.10K | -137.14% |
Net change in cash | -673.92K | -44.76% |
Free cash flow | -528.10K | 35.65% |
About
Founded
2001
Headquarters
Website
